Brief: Neurocrine Biosciences Appoints Mike Sibley As Senior Vice President, General Manager Of Neuropsychiatry Franchise
06/10/2025 23:51
Oct 6 (Reuters) - Neurocrine Biosciences Inc NBIX.O: NEUROCRINE BIOSCIENCES APPOINTS MIKE SIBLEY AS SENIOR VICE PRESIDENT, GENERAL MANAGER OF NEUROPSYCHIATRY FRANCHISE Source text: ID:nPn7tzbJda Further company coverage: NBIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurocrine Biosciences
See all newsBrief: Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating Nbi-'567 In Adults With Alzheimer's Disease
Nxera Pharma's Partner Neurocrine Biosciences Receives Ind Acceptance From FDA For Phase 2 Study Of Nbi-1117567 For Alzheimer's Cognition
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Prader-Willi groups cite deaths tied to Neurocrine's genetic disorder drug, shares fall